What is Cortrium?
Cortrium offers a comprehensive ECG monitoring system designed for patient comfort and healthcare provider efficiency. The solution includes the waterproof and cable-free C3 monitor, cloud-based Apex software for data analysis, and verified ECG reports. By ensuring all detected arrhythmias are verified by cardiology specialists and emphasizing quick data accessibility, Cortrium aims to enhance the delivery of effective cardiac treatment. The company's focus on reliability and ease of use makes its technology a valuable asset for healthcare professionals managing heart patients.
How much funding has Cortrium raised?
Cortrium has raised a total of $1.6M across 1 funding round:
Unspecified
$1.6M
Unspecified (2015): $1.6M with participation from Myant & Co.
Key Investors in Cortrium
Myant & Co.
Myant & Co. is an innovative company focused on integrating sensors and actuators into textiles to create smart fabrics capable of sensing and reacting to the human body. Their healthcare division, MyantHealth, aims to make healthcare more equitable and accessible through a connected care platform for cardiovascular health, connecting patients with their families and practitioners.
What's next for Cortrium?
The recent major strategic investment signifies a pivotal moment for Cortrium, likely enabling the company to scale its operations, enhance its technological offerings, and broaden its market reach. This capital will be instrumental in further developing its patient-friendly ECG monitoring solutions and expanding its footprint within the global healthcare sector. The company's commitment to providing verified ECG reports and accessible data suggests a strategic focus on clinical validation and integration into existing healthcare workflows, positioning it for sustained growth and impact in cardiac care.
See full Cortrium company page
